Tuberculosis Trials in Rio de Janeiro, Brazil
Conditions / Tuberculosis / Rio de Janeiro, Brazil
Research into Tuberculosis spans multiple therapeutic approaches and trial phases.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00822315 | Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis | COMPLETED | PHASE2 |
| NCT00164450 | TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection | COMPLETED | NA |
| NCT03819114 | Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy | COMPLETED | PHASE2 |
| NCT00023452 | Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection | COMPLETED | PHASE3 |
| NCT00107887 | TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) | COMPLETED | PHASE4 |
| NCT00144417 | TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment | COMPLETED | PHASE2 |
| NCT04518228 | Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum | COMPLETED | — |
| NCT00533390 | Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg | TERMINATED | PHASE4 |
| NCT01404312 | Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) | COMPLETED | PHASE3 |
| NCT06497465 | Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment | RECRUITING | PHASE3 |